Abstract
Parvoviruses are small nuclear replicating DNA viruses. The rodent parvoviruses are usually weakly pathogenic in adult animals, bind to cell surface receptors which are fairly ubiquitously expressed on cells, and do not appear to integrate into host chromosomes during either lytic or persistent infection. The closely related rodent parvoviruses MVM, H-1 and LuIII efficiently infect human cell lines. Most interesting, malignant transformation of human and rodent cells was often found to correlate with a greater susceptibility to parvovirus-induced killing (oncolysis) and with an increase in the cellular capacity for amplifying and / or expressing the incoming parvoviral DNA. These and other interesting properties make these autonomous rodent parvoviruses and recombinant derivatives promising candidate antitumor vectors. Capsid replacement vectors have been produced from MVM or H-1 virus that carry transgenes encoding either therapeutic products (cytokines/chemokines, Apoptin, herpes simplex virus thymidine kinase) or marker proteins (green fluorescent protein, chloramphenicolacetyl transferase, luciferase). This review describes the current state of the art regarding the potential application of wild-type parvoviruses and derive...Continue Reading
Citations
Oct 28, 2011·BMC Cancer·Markus MoehlerPeter R Galle
Dec 13, 2006·Journal of Nanobiotechnology·Leona GilbertChristian Oker-Blom
May 12, 2012·Cancer Immunology, Immunotherapy : CII·Sebastian DempeChristiane Dinsart
Mar 12, 2015·International Journal of Oncology·Il-Rae ChoYoung-Hwa Chung
Feb 9, 2010·Trends in Molecular Medicine·Stefan Grimm, Mathieu Noteborn
Oct 20, 2009·European Journal of Pharmacology·Mathieu H M Noteborn
Apr 28, 2009·Advanced Drug Delivery Reviews·Dominik E Dorer, Dirk M Nettelbeck
Mar 27, 2007·Cancer Letters·Markus J V Vähä-KoskelaAri E Hinkkanen
Jun 27, 2006·The Journal of Gene Medicine·Susanne I LangJan J Cornelis
Jun 21, 2012·Journal of Digestive Diseases·Yuan Yuan WangZheng Wang
Oct 27, 2009·International Journal of Cancer. Journal International Du Cancer·Sebastian DempeChristiane Dinsart
Dec 27, 2012·Journal of Proteomics·Pierre GarcinNelly Panté
Dec 17, 2014·Cytokine & Growth Factor Reviews·Katrien Van RaemdonckSofie Struyf
May 4, 2005·Virology·Susan F Cotmore, Peter Tattersall
Apr 7, 2005·Digestive Diseases·Daniëlle A M Heideman
Sep 3, 2005·Cancer Gene Therapy·S E LawlerE A Chiocca
Jan 19, 2008·Cancer Gene Therapy·L KrügerJ A Kleinschmidt
Jan 25, 2007·Basic & Clinical Pharmacology & Toxicology·Sharon J OlijslagersMathieu H M Noteborn
Jul 11, 2006·The Journal of Biological Chemistry·Hyun-Joo NamMavis Agbandje-McKenna
Jun 21, 2019·Viruses·Clemens Bretscher, Antonio Marchini
Apr 28, 2011·Experimental Biology and Medicine·Konstantinos ArgirisMahvash Tavassoli
Apr 11, 2006·The Journal of General Virology·Charlotte ServaisAnnick Brandenburger
Sep 24, 2005·Journal of Cell Science·Subbareddy MaddikaMarek Los
Jul 13, 2021·JCO Precision Oncology·Omeed MoavenMitesh J Borad